Search Result "nondopaminergic"


General Review Article

An Update on Nondopaminergic Treatments for Motor and Non-motorSymptoms of Parkinson’s Disease

Journal: Current Neuropharmacology
Volume: 21 Issue: 8 Year: 2023 Page: 1806-1826
Author(s):

Current Strategies for the Development of Novel Antipsychotic Drugs

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 3 Issue: 3 Year: 2003 Page: 239-251
Author(s): Jordi Bolos

Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 6 Year: 2011 Page: 670-684
Author(s): M. A. Cenci, K. E. Ohlin, P. Odin

General Review Article open access plus

Pharmacologic Treatment of Restless Legs Syndrome

Journal: Current Neuropharmacology
Volume: 19 Issue: 3 Year: 2021 Page: 372-382
Author(s): Qing Lv,Xinlin Wang,Tetsuya Asakawa,Xiao Ping Wang

General Review Article

Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease

Journal: Current Medicinal Chemistry
Volume: 27 Issue: 12 Year: 2020 Page: 2021-2036
Author(s): Alexandra Kasabova-Angelova,Diana Tzankova,Javor Mitkov,Maya Georgieva,Virginia Tzankova,Alexander Zlatkov,Magdalena Kondeva-Burdina

α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease

Journal: Current Drug Targets
Volume: 13 Issue: 5 Year: 2012 Page: 623-630
Author(s): Jun Kawamata, Syuuichirou Suzuki, Shun Shimohama

Mini-Review Article

Novel Treatment for the Most Resistant Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant

Journal: Current Drug Targets
Volume: 21 Issue: 6 Year: 2020 Page: 610-615
Author(s): Chieh-Hsin Lin,Yu-Ming Chen,Hsien-Yuan Lane

Review Article

Monoamine Oxidase B Inhibitors in Parkinson's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 4 Year: 2017 Page: 425-439
Author(s): Livia Dezsi,Laszlo Vecsei

Role of Neural Stem Cells in Parkinsons Disease

Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 3 Year: 2011 Page: 337-340
Author(s): Rebeca Millan-Guerrero

Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson’s Disease: Bridging Molecular Studies and Clinical Trials

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12 Issue: 8 Year: 2013 Page: 1128-1142
Author(s): A. Vallano,V. Fernandez-Duenas,G. Garcia-Negredo,M.A. Quijada,C.P. Simon,M.L. Cuffí,L. Carbonell,S. Sanchez,J.M. Arnau,F. Ciruela

Previous   Next

Go to   Results 1 - 1 of 46

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads